Ribometrix
Katie Warner is a highly accomplished professional in the field of RNA biology, with extensive experience working at Ribometrix Inc. as a Senior Vice President, Co-Founder, Vice President, Sr. Director of Research, and Director of Research. Prior to their current role, Katie worked at the National Institutes of Health as a Postdoctoral Research Fellow. Katie holds a Doctor of Philosophy (PhD) in Chemistry from the University of Cambridge, a Master of Philosophy (MPhil) in Pathology from the same university, and a Bachelor's Degree in Chemistry from the University of North Carolina at Chapel Hill.
This person is not in any offices
Ribometrix
Ribometrix, headquartered in Durham, North Carolina, is a biotechnology company leveraging world-leading expertise in three-dimensional structural analysis of RNA as the foundation of its proprietary drug discovery platform. This platform enables the identification of novel small molecules that modulate the function of RNA and proteins associated with human disease. Ribometrix’ value creation strategy is built around developing an internal pipeline of drug candidates and partnerships with the leading biopharmaceutical companies. Ribometrix is backed by a syndicate of blue-chip venture investors.